[Use of biocompatible polymer implants in combination with extrafocal device fixation in the surgical treatment of spondylitis].
The author summarized the data on experimental application of biocompatible implants IIIIIM-1 covered with benemycin as a treatment modality in spondylitis. The polymer implanted into the disease focus is able to maintain high concentration of the drug for 60 days. The implants were inserted in 120 tuberculous and 27 nonspecific spondylitis patients. Surgical intervention performed in 147 patients comprising radical resection of the destruction focus and vertebral defect replacement with biocompatible implant in combination with extrafocal apparatus fixation decreased the operation trauma++, secured stability of the anterior and posterior parts of the operated spine and allowed early active rehabilitation of postoperative patients, 2-3 months after the surgery the author observed good spinal stabilization and definite signs of clavus formation in the resection zone.
Lavrov
V N
VN
D000368:Aged; D000818:Animals; D018786:Bone Substitutes; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009984:Orthopedic Fixation Devices; D011817:Rabbits; D013166:Spondylitis / Q000150:complications / Q000601:surgery*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000150:complications*
D018786:Bone Substitutes
Primenenie biosovmestimykh polimernykh implantatov v sochetanii s vneochagovoĭ apparatnoĭ fiksatsieĭ v khirurgicheskom lechenii spondilitov.